Powered by OpenAIRE graph

IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes

assignment_turned_inproject08 Jun 2016(Started)-31 May 2021(Ended)Closed
Funder: National Institutes of HealthProject code: 5R01AI121250-05
Funded under: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES Funder Contribution: 586,684 USD

IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes

Data Management Plans
argos Start a new DMP in Argos
Powered by OpenAIRE graph

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

All Research products
arrow_drop_down
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=nih_________::23a0bf2c09ec43d32d30a37cf0975164&type=result"></script>');
-->
</script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

No option selected
arrow_drop_down